Neonc Technologies Holdings, Inc. (NTHI)
NTHI Stock Price Chart
Explore Neonc Technologies Holdings, Inc. interactive price chart. Choose custom timeframes to analyze NTHI price movements and trends.
NTHI Company Profile
Discover essential business fundamentals and corporate details for Neonc Technologies Holdings, Inc. (NTHI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Mar 2025
Employees
8.00
Website
https://www.neonctech.comCEO
Amir Farrokh Heshmatpour
Description
Neonc Technologies Holdings, Inc. specializes in pioneering molecular advancements aimed at improving the targeted administration of therapies for central nervous system disorders. The company's leading pipeline candidate, NEO100, is presently undergoing Phase 2a clinical trials for the treatment of glioblastoma. Additionally, NEO212, a unique molecular construct chemically linking the chemotherapeutic agent temozolomide with perillyl alcohol, has successfully concluded its preclinical evaluation. This enterprise, founded in 2023, operates from its base in Los Angeles, California.
NTHI Financial Timeline
Browse a chronological timeline of Neonc Technologies Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 14 Aug 2026
EPS estimate is -$0.12.
Earnings released on 18 May 2026
EPS came in at -$0.38 falling short of the estimated -$0.22 by -73.52%.
Earnings released on 31 Mar 2026
EPS came in at -$0.40 falling short of the estimated -$0.37 by -7.31%.
Earnings released on 14 Nov 2025
EPS came in at -$0.45 falling short of the estimated -$0.37 by -21.62%.
NTHI Stock Performance
Access detailed NTHI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
